NYSE$NHC
National HealthCare Corporation · Q2 2025 earnings
Q2 2025 earnings · · Before market open · Investor relations
Reports in 3 weeks
NHC hasn't published Q2 2025 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.
Most recent report Q1 2026
- Revenue
- $382M
- EPS
- $2.27
Year-ago · Q2 2024 Q2 2024
- Revenue
- $301M
- EPS
- $1.73
Revenue & EPS history
NHC · Revenue · Quarterly
$382M
Q1 2026+2.2%vs Q1 2025
Historical revenue by segment
NHC · $260M total across 2 segments · Q1 2023
- Net patient revenues$258M+2.8%99.2%
- Other revenues$2.06M-87.5%0.8%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports
+0.1%
Avg return
Earnings day
+1.7%
Avg return
5 days after
+1.8%
Avg return
30 days after
60%
39 / 65 earnings
Positive
+12.2%
Q2 2023
Best reaction
-14.0%
Q4 2009
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.8% | +11.8% | +12.9% | |
| Q4 2025 | +2.0% | -4.7% | -3.7% | |
| Q3 2025 | +1.1% | +3.4% | +7.8% | |
| Q1 2025 | +1.6% | -3.1% | -3.3% | |
| Q4 2024 | +0.8% | +0.1% | -0.2% | |
| Q3 2024 | +4.5% | -0.1% | -4.8% | |
| Q2 2024 | +3.2% | +3.7% | +6.4% | |
| Q1 2024 | +0.9% | +4.4% | +7.4% | |
| Q4 2023 | +5.8% | +7.1% | -0.1% | |
| Q3 2023 | +1.8% | +3.9% | +14.2% | |
| Q2 2023 | +12.2% | +12.6% | +12.5% | |
| Q1 2023 | +1.9% | +5.4% | +11.5% | |
| Q4 2022 | -2.4% | -3.9% | -8.2% | |
| Q3 2022 | -3.2% | -1.0% | -1.3% | |
| Q2 2022 | +1.1% | +1.9% | +0.8% | |
| Q1 2022 | +2.8% | +0.8% | +1.9% | |
| Q4 2021 | +0.5% | +0.4% | +9.6% | |
| Q3 2021 | +5.9% | +1.3% | -10.0% | |
| Q2 2021 | -0.8% | -2.4% | -5.9% | |
| Q1 2021 | -1.5% | -1.6% | +2.4% | |
| Q4 2020 | +3.7% | +10.3% | +20.5% | |
| Q3 2020 | -1.8% | +13.0% | +2.3% | |
| Q2 2020 | +5.8% | +5.0% | -1.2% | |
| Q1 2020 | -0.0% | -5.0% | +5.4% | |
| Q4 2019 | -0.2% | -8.4% | -16.6% | |
| Q3 2019 | -0.4% | +0.1% | +1.1% | |
| Q2 2019 | -0.6% | +0.4% | -5.3% | |
| Q1 2019 | +0.1% | +1.4% | +2.3% | |
| Q4 2018 | +1.8% | -0.2% | -4.2% | |
| Q3 2018 | -2.3% | -3.5% | -2.1% | |
| Q2 2018 | +1.7% | +4.4% | +5.3% | |
| Q1 2018 | +3.0% | +3.8% | +8.3% | |
| Q4 2017 | -7.1% | -2.5% | -3.3% | |
| Q3 2017 | -1.0% | +2.9% | +0.4% | |
| Q2 2017 | +0.0% | +2.3% | -3.8% | |
| Q1 2017 | -1.1% | -1.2% | -2.2% | |
| Q4 2016 | +1.0% | +0.8% | +0.3% | |
| Q3 2016 | -2.1% | +1.0% | +7.6% | |
| Q2 2016 | +1.9% | +2.6% | +4.7% | |
| Q1 2016 | -0.6% | — | — | |
| Q4 2015 | -1.6% | — | — | |
| Q3 2015 | +0.5% | — | — | |
| Q2 2015 | -3.4% | — | — | |
| Q1 2015 | +0.1% | — | — | |
| Q4 2014 | +1.0% | — | — | |
| Q3 2014 | +1.9% | — | — | |
| Q2 2014 | +0.4% | — | — | |
| Q1 2014 | +2.3% | — | — | |
| Q4 2013 | -0.4% | — | — | |
| Q3 2013 | +0.7% | — | — | |
| Q2 2013 | +1.5% | — | — | |
| Q1 2013 | -0.3% | — | — | |
| Q4 2012 | +1.2% | — | — | |
| Q3 2012 | +1.8% | — | — | |
| Q2 2012 | -1.0% | — | — | |
| Q1 2011 | -4.9% | — | — | |
| Q1 2012 | +3.2% | — | — | |
| Q4 2011 | -0.9% | — | — | |
| Q3 2010 | +7.9% | — | — | |
| Q3 2011 | +7.9% | — | — | |
| Q4 2009 | -14.0% | — | — | |
| Q4 2010 | -14.0% | — | — | |
| Q2 2010 | -14.0% | — | — | |
| Q2 2011 | -14.0% | — | — | |
| Q1 2010 | +3.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro